Ceribell, Inc. (CBLL) stock

CBLLNasdaqElectromedical & Electrotherapeutic ApparatusFiscal year ends December 31

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 3, 2026Score 6/30150% above fair value

$26.35−1.45 (-5.22%)

Close on Nov 12, 2026Market cap $1.01BP/E –Yield –

Ceribell statistics

81 measures from SEC filings and the closing price. Hover a name for the formula; the last column is the median of companies in the same industry group.

Important dates

Next earnings: Feb 23, 2027 (estimated, after the close)
Last ex-dividend date: No dividends
Fundamentals through: Jun 30, 2026
Share price as of: Nov 12, 2026

Valuation ratiosIndustry

Market Cap: $1.01B; $501.02M
Enterprise Value: $901.94M; $422.54M
PS Ratio: 9.92; 3.04
PB Ratio: 7.88; 3.29
P/TBV Ratio: 7.88; 4.85

Enterprise valuationIndustry

EV / Sales: 8.85; 2.70

Share statisticsIndustry

Shares Outstanding: 38M; 43M
Shares Change (QoQ): 0.96%; 0.16%
Float: 28M; 37M
Shares Held by Insiders: 26.7%; 10.5%
Shares Held by Institutions: 79.5%; 60.2%

Short sellingIndustry

Short Interest: 2M; –
Short Interest Change: -9.24%; -2.57%
Short % of Float: 6.96%; 5.12%
Short % of Shares Outstanding: 5.10%; 3.98%
Days to Cover: 3.55; 3.94

Stock price statisticsIndustry

52-Week High: $28.89; –
52-Week Low: $12.36; –
20-Day Moving Average: $27.04; –
50-Day Moving Average: $25.49; –
200-Day Moving Average: $21.01; –
Average True Range (14): $1.57; –
Price Change (1 Week): 1.31%; 2.01%
Price Change (1 Month): -0.08%; -0.57%
Price Change (3 Months): 12.9%; -7.91%
Price Change (6 Months): 60.1%; -0.90%
Price Change (YTD): 20.2%; -0.82%
Price Change (1 Year): 110.5%; -1.18%
Average Volume (10 Days): 622,674; –
Average Volume (20 Days): 590,859; –
Average Volume (90 Days): 433,718; –
Relative Volume: 1.11; 0.82
Relative Strength Index (14): 49.2; 47.7
Volatility (1 Year): 51.1%; 64.2%
Beta (5 Years): 0.82; 1.05

MarginsIndustry

Gross Margin: 88.9%; 55.9%
Operating Margin: -68.6%; -5.17%
Pretax Margin: -64.7%; -2.55%
Profit Margin: -64.7%; -9.23%
EBITDA Margin: -67.6%; -2.82%
FCF Margin: -53.7%; 0.40%

Returns on capitalIndustry

Return on Equity (ROE): -43.9%; -17.1%
Return on Assets (ROA): -35.3%; -12.2%
Return on Invested Capital (ROIC): -330.7%; -3.22%
Return on Capital Employed (ROCE): -46.9%; -8.13%

Financial positionIndustry

Current Ratio: 9.18; 2.45
Quick Ratio: 8.45; 1.53
Debt / Equity: 0.16; 0.42
Interest Coverage: -38.57; -1.68

GrowthIndustry

Revenue Growth (YoY): 31.7%; 9.24%

EfficiencyIndustry

Asset Turnover: 0.55; 0.59
Inventory Turnover: 1.78; 2.20
Revenue Per Employee: $311.82K; $330.60K
Profits Per Employee: -$201.83K; -$41.39K
Employee Count: 327; 186
WACC: 8.94%; 9.71%

Income statement (TTM)Industry

Revenue: $101.96M; $106.81M
Gross Profit: $90.65M; $62.29M
Operating Income: -$69.97M; -$4.10M
Pretax Income: -$66.00M; -$1.69M
Net Income: -$66.00M; -$6.19M
EBITDA: -$68.95M; -$1.98M
EPS (Diluted): -$1.76; -$0.08

Balance sheetIndustry

Cash & Short-Term Investments: $129.30M; $38.08M
Total Debt: $19.98M; $96.00M
Net Cash (Debt): $109.32M; $3.73M
Net Cash Per Share: $2.85; $0.24
Equity (Book Value): $128.31M; $63.44M
Book Value Per Share: $3.34; $3.26
Tangible Book Value: $128.31M; $11.04M
Working Capital: $140.65M; $56.85M

Cash flow (TTM)Industry

Operating Cash Flow: -$54.03M; -$541.49K
Capital Expenditures: -$690.00K; -$3.69M
Free Cash Flow: -$54.72M; -$387.37K
FCF Per Share: -$1.43; -$0.01

Dividends and yieldsIndustry

Earnings Yield: -6.53%; -4.70%
FCF Yield: -5.41%; 0.24%

Taxes and interestIndustry

Interest Expense: $1.81M; $5.33M

Scores and fair valueIndustry

Altman Z-Score: 14.01; 2.44
Piotroski F-Score: 3; 5
Beneish M-Score: -2.44; -2.64

Total return vs. the S&P 500

Price change plus reinvested dividends, to the close on Nov 12, 2026. The S&P 500 is measured by the SPY fund.

Period	CBLL	S&P 500	Difference
1 month	+4.3%	-2.7%	+7.0 pts
3 months	+15.0%	-1.7%	+16.8 pts
Year to date	+20.2%	+11.9%	+8.3 pts
1 year	+105.1%	+12.0%	+93.1 pts

Short interest

Shares sold short and not yet covered, reported by brokers to FINRA twice a month. Latest settlement date Oct 30, 2026.

2M CBLL shares were sold short on Oct 30, 2026, down 9.2% from the previous report, or 6.96% of the shares available to trade. At recent volumes it would take 3.5 days to buy them back. Over the last 20 sessions, 48.7% of the volume reported to FINRA was short selling.

Settlement date	Shares short	Change	Avg. daily volume	Days to cover
Oct 30, 2026	1,956,647	-9.2%	550,613	3.5
Oct 15, 2026	2,155,957	+6.8%	449,746	4.8
Sep 30, 2026	2,017,836	+10.9%	400,380	5.0
Sep 15, 2026	1,818,916	-4.6%	297,450	6.1
Aug 31, 2026	1,906,873	-9.3%	341,683	5.6
Aug 14, 2026	2,102,642	+4.2%	502,297	4.2
Jul 31, 2026	2,018,217	+9.2%	369,507	5.5
Jul 15, 2026	1,847,515	-6.5%	338,606	5.5
Jun 30, 2026	1,975,534	-1.8%	450,499	4.4
Jun 15, 2026	2,011,887	+4.7%	287,606	7.0
May 29, 2026	1,921,679	-2.1%	263,873	7.3
May 15, 2026	1,962,041	+4.1%	402,450	4.9